Home » Authors » Trista Morrison

Articles by Trista Morrison

No Public Funds or Partners: Can Istodax Be New Approval Model?

Nov. 16, 2009

By Trista Morrison

Maxygen Buying Back Stock; Analysts Say No Trend Here

Nov. 16, 2009

By Trista Morrison

Maxygen Inc. on Friday became the latest member of a very small biotech cadre that is returning cash to shareholders. (BioWorld Today)

Altus Shares Hit Rock Bottom as Firm Files for Bankruptcy

Nov. 13, 2009

By Trista Morrison

BioVex's $70M Series F to Fund Pivotal OncoVex Melanoma Trial

Nov. 11, 2009

By Trista Morrison

Trius and Alimera Join Growing Roster of Biotech IPO Hopefuls

Nov. 10, 2009

By Trista Morrison

Returning Money to Investors: Still the Exception, Not the Rule

Nov. 9, 2009

By Trista Morrison

Genmab Still Cutting: 300 Jobs and Manufacturing Next to Go

Nov. 9, 2009

By Trista Morrison

NewCo News: Kalos Hits Financing Trail for Peptide-Based MAPK Inhibitor

Nov. 5, 2009

By Trista Morrison

HCV Vaccines, TLRs Advance Away from Protease Spotlight

Nov. 4, 2009

By Trista Morrison

HCV Vaccines, TLRs Advance Away from Protease Spotlight

Nov. 2, 2009

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...